On 8 and 9 November 2022, the Maternal Immunization Working Group (MIWG) held an in-person and online hybrid meeting. The objectiv...

Effective safety monitoring of COVID-19 vaccines must go beyond the use of passive surveillance, which is typically used to...

In recognition of the increasing importance of viral vectors for the development of new vaccines and the need to understand their...

The Brighton Collaboration (BC) Viral Vector Vaccines Safety Working Group (V3SWG) was renamed to Benefit-Risk Assessment of VAcci...